Key Highlights

  • UiPath (NYSE:PATH) traded at USD 13.38 on October 13, 2026, up 0.45% on 34.245 million shares (0.5 times the 3-month average), valued at USD 6.905 billion, with a P/E of 19.37 and a PEG of 0.94.
  • No company release or analyst action dated October 13, 2026 was found for the 0.45% gain, which came on volume about half the 3-month average, so no catalyst is identified.
  • The bigger event was a September 28 downgrade to Underperform with a USD 10 target by DA Davidson after the investor day, citing AI pricing concerns, and published reports said September was heading for the worst month in four years.
  • A P/E of 19.37 sits just inside the filter band, and a PEG of 0.94 is below 1, though the growth rate behind it comes from a very low earnings base.

Catalyst and Latest Updates

UiPath (NYSE:PATH) rose USD 0.06 to USD 13.38 on 34.245 million shares, about half its 3-month average of 65.834 million, so the move is small and quiet. No release or analyst action dated October 13, 2026 was found. At its September 22 analyst day the company set long-term targets for a gross margin of 80% or more and an operating margin of 30% or more. BMO, TD Cowen, Canaccord and UBS cut targets to USD 15, USD 15, USD 14 and USD 14 on September 24 and 25, and DA Davidson downgraded on September 28. Between October 6 and 9 it was named a leader in Forrester, Everest Group and Gartner evaluations.

What the Valuation Figures Mean

UiPath sells an automation platform that combines robotic process automation with AI agents. Trailing revenue is about USD 1.72 billion, up 15%, and net income about USD 362 million, per published data, a large rise from a very low base, which is why the earnings growth filter passes. A P/E of 19.37 means about USD 19.37 is paid for each USD 1 of past-year earnings. The PEG of 0.94 is under 1, conventionally read as reasonable relative to growth, but revenue grew only 15%, so the earnings jump is not a sign of equal sales growth. Revenue growth of 15% is moderate, so a P/E near the top of the band is demanding.

Risks and What to Watch

The key risk is pricing: if AI agents reduce the number of paid automation seats or bots, revenue per customer could fall, which is the concern DA Davidson raised. At USD 13.38 the stock is about 33% below its 52-week high of USD 19.84 and about 45% above its low of USD 9.20, simple arithmetic on published figures. The published consensus is Hold from 21 analysts with a target near USD 15.50, which is not our forecast. Fiscal third quarter results are estimated for December 2, 2026, and they will show growth and margins against the new long-term targets. Competition from larger software vendors also affects pricing and renewal terms.

Where Things Stand

The answer is that no catalyst was found for the 0.45% gain, and the stock's real story is the September downgrade and target cuts over AI pricing worries. UiPath (NYSE:PATH) shows a P/E of 19.37 and a PEG of 0.94, but a low earnings base inflates the growth figure. Results estimated for December 2, 2026 are the next test. The balance of evidence is mixed: strong industry recognition and long-term targets sit beside analyst caution.